Blonder Tongue Laboratories, Inc. (NYSEAMERICAN:BDR)’s share price gapped up before the market opened on Tuesday . The stock had previously closed at $1.37, but opened at $1.57. Blonder Tongue Laboratories shares last traded at $1.45, with a volume of 4,820 shares traded.

The company has a fifty day moving average price of $1.20. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.48 and a current ratio of 1.32.

Blonder Tongue Laboratories (NYSEAMERICAN:BDR) last posted its quarterly earnings data on Wednesday, November 11th. The technology company reported ($0.18) earnings per share (EPS) for the quarter. The company had revenue of $4.17 million for the quarter. Blonder Tongue Laboratories had a negative return on equity of 180.97% and a negative net margin of 52.07%.

In related news, Director Robert J. Palle, Jr. sold 40,029 shares of the company’s stock in a transaction dated Thursday, December 17th. The shares were sold at an average price of $1.30, for a total value of $52,037.70. Following the sale, the director now owns 2,524,973 shares of the company’s stock, valued at $3,282,464.90. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 63.42% of the company’s stock.

A hedge fund recently bought a new stake in Blonder Tongue Laboratories stock. Virtu Financial LLC acquired a new position in shares of Blonder Tongue Laboratories, Inc. (NYSEAMERICAN:BDR) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 55,897 shares of the technology company’s stock, valued at approximately $46,000. Virtu Financial LLC owned about 0.55% of Blonder Tongue Laboratories at the end of the most recent quarter. 5.62% of the stock is currently owned by institutional investors and hedge funds.

About Blonder Tongue Laboratories (NYSEAMERICAN:BDR)

Blonder Tongue Laboratories, Inc, a technology-development and manufacturing company, provides television (TV) signal encoding, transcoding, digital transport, and broadband product solutions in the United States. It offers digital video headend products comprising high definition and standard definition, MPEG-2, and MPEG-4/H.264 encoders and transcoders; satellite quadrature phase shift key and eight phase shift key to quadrature amplitude modulation (QAM) transcoders; digital QAM multiplexers; ATSC/QAM-IP transcoders; EdgeQAM devices; and NeXgen Gateway, a digital video signal processing platform to system operators for the acquisition, processing, compression, encoding, and management of digital videos.

Further Reading: Accumulation/Distribution

Receive News & Ratings for Blonder Tongue Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blonder Tongue Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.